232 - Population Pharmacokinetics (PopPK) of Ceftazidime-Avibactam (CZA) in Combination with Aztreonam (ATM) in a Phase I, Open-Label Study in Healthy Adult Subjects (COMBINE)

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

JO

J Nicholas O'Donnell, Pharm.D.

Assistant Professor
Albany College of Pharmacy and Health Sciences
Albany, New York, United States
SB

Stephen Balevic, MD

Duke Clinical Pharmacometrics Center, Duke Clinical Research Institute (DCRI), Duke University School of Medicine
Durham, North Carolina, United States
xl

xing liu, Ph.D.

Duke Clinical Pharmacometrics Center, Duke Clinical Research Institute (DCRI)
durham, North Carolina, United States
KG

Kenan Gu, PhD

NIAID
Rockville, Maryland, United States
jg

jomy george, Pharm.D.

Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Bethesda, Maryland, United States
SR

Shruti Raja, MD

Duke Early Phase Clinical Research Unit, Duke Clinical Research Institute (DCRI), Duke University School of Medicine
Durham, North Carolina, United States
JG

Jeffrey Guptill, MD

Duke University School of Medicine
Durham, North Carolina, United States
SZ

Smitha Zaharoff, Ph.D.

Assistant Director
Duke Clinical Research Institute (DCRI)
durham, North Carolina, United States
ns

nyssa schwager, MSN, RN

Duke Clinical Research Institute (DCRI)
durham, North Carolina, United States
Vance G. Fowler, Jr, MD, MHS

Professor of Medicine
Duke University Medical Center
Durham, North Carolina, United States
henry chambers, MD

Professor
University of California, San Francisco, and San Francisco General Hospital
San Francisco, California, United States